Back

Paradigm Medical Communications, LLC

  • Lupus Erythematosus, Systemic

Case-by-Case: Applying New Evidence to the Treatment of Systemic Lupus Erythematosus

The treatment of nonrenal systemic lupus erythematosus (SLE) is expected to evolve as new agents emerge for treatment. How do these agents work? What are the efficacy and safety data? And how should these be incorporated into guideline-aligned treatment of SLE? Our faculty discusses these in the context of 2 case examples illustrating their thought process in selecting treatment for SLE.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

No specific specialties targeted.

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    Jul 31, 2026
  • Last day to claim credit
    Aug 1, 2027 10 months left